SCHEMBL1928092

SCHEMBL1928092

CCCNC(=O)c1ccc(-c2ccc(C)cc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.68
POLB P06746 2/20 0.64
LMNA P02545 1/20 0.64
DRD2 P14416 1/20 0.59
DRD4 P21917 1/20 0.59
DRD3 P35462 1/20 0.59
NPC1 O15118 6/20 0.57
RAB9A P51151 5/20 0.57
KMT2A Q03164 2/20 0.57
KDM4E B2RXH2 2/20 0.57
SMN1; SMN2 Q16637 3/20 0.55
MMP13 P45452 1/20 0.55
GAA P10253 2/20 0.54
ALDH1A1 P00352 2/20 0.54
NPSR1 Q6W5P4 1/20 0.53
CDK4 P11802 1/20 0.52
CCND1 P24385 1/20 0.52
MAPK14 Q16539 1/20 0.52
ABL1 P00519 1/20 0.52
BCR P11274 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL765958 0.94 L3MBTL1 (0.74) L3MBTL1POLBLMNANPC1RAB9A
SCHEMBL15782158 0.90 L3MBTL1 (0.79) L3MBTL1POLBLMNADRD2DRD4
SCHEMBL13918749 0.87 KDM4E (0.70) L3MBTL1POLBLMNADRD2DRD4
SCHEMBL1927649 0.86 DRD2 (0.77) L3MBTL1POLBLMNADRD2DRD4
SCHEMBL11220601 0.85 LMNA (0.85) L3MBTL1POLBLMNANPC1RAB9A
SCHEMBL1928116 0.84 ERN1 (0.64) L3MBTL1POLBLMNADRD2DRD4
SCHEMBL1927651 0.84 CYP1A2 (0.62) L3MBTL1POLBDRD2DRD4DRD3
SCHEMBL178367 0.84 L3MBTL1 (0.87) L3MBTL1POLBLMNANPC1RAB9A
SCHEMBL13577911 0.82 L3MBTL1 (0.97) L3MBTL1POLBLMNADRD2DRD4
SCHEMBL1926254 0.81 NPC1 (0.69) POLBDRD2DRD4DRD3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1763509-B1 ALPHA-HELICAL MIMETICS WALTER & ELIZA HALL INST MEDICAL RES (AU) 2018-02-21 EP disclosed
US-7956216-B2 Benzoyl urea derivatives mimicing BH3-only proteins, able to interact with a Bcl-2 protein THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2011-06-07 US disclosed
US-20080153802-A1 Alpha-helical mimetics THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2008-06-26 US disclosed
EP-1763509-A1 ALPHA-HELICAL MIMETICS THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2007-03-21 EP disclosed
WO-2006002474-A1 ALPHA-HELICAL MIMETICS THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153802-A1 Alpha-helical mimetics BID, BAX, BAD L3MBTL1 85/4885POLB 2096/4885LMNA 454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.